Rohit Gupta, MD, discusses advanced pulmonary sarcoidosis, antifibrotic uncertainty, and first-line methotrexate data after a CHEST 2026 session.
Rohit Gupta, MD
Advertisement
Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University
Director, Sarcoidosis Program, Temple University Hospital
Articles by Rohit Gupta, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Experts Discuss PAH Treatment Selection and Access
2
Mitapivat PDUFA Date for Sickle Cell Disease Extended to February 2027
3
Nalbuphine ER Rapidly Eases IPF Cough Burden, With Phil Molyneaux, MD, PhD
4
Imlifidase Opens a Transplant Window, With Oriol Bestard, MD, PhD
5